Susvimo™ (ranibizumab injection)
for Macular Degeneration

Susvimo (ranibizumab injection) is used to treat adults with neovascular (wet) age-related macular degeneration (AMD) or diabetic macular edema (DME) who have responded to at least two prior VEGF inhibitor injections. It works by blocking VEGF-A, a protein that causes abnormal blood vessel growth and leakage in the eye. By stopping VEGF-A activity, Susvimo helps prevent vision loss and reduces fluid buildup in the retina.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Macular Degeneration